Q3 2022 Holdings
Filed 2022-11-14 | 15 holdings | $78.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $40.3M | 1,218,515 | 51.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $29.9M | 671,745 | 37.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $8.5M | 24,000 | 10.7% |
| S&P Biotech ETF TR(XBI)Put | UNIT | 78464A870 | $39.7K | 500,000 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $34.5K | 524,268 | 0.0% |
| Merus N V | COM | N5749R100 | $30.2K | 1,507,109 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $25.6K | 967,684 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $15.8K | 841,471 | 0.0% |
| Amryt Pharma PLC | SPONSORED ADS | 03217L106 | $13.8K | 1,998,993 | 0.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $12.7K | 1,263,125 | 0.0% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $7.9K | 244,848 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $7.2K | 330,246 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $6.8K | 3,403,210 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $4.6K | 4,036,280 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $29 | 3,573 | 0.0% |